General Exercise Guidance
You just started a GLP-1 medication and the weight is coming off. Maybe faster than anything you’ve tried before. So here’s the question that comes up almost immediately: do I need to exercise too?
The short answer is yes. But not for the reason you think.
If your first thought was “exercise to burn more calories and lose weight faster” — that’s the old framework, and it doesn’t apply here anymore. GLP-1 medications are so effective at driving weight loss that the entire conversation around exercise has shifted. The goal isn’t burning calories. The goal is making sure the weight you lose is the right kind of weight, and that the body you’re left with actually works better than it did before.
This page covers why exercise matters on GLP-1 medications, what the current guidelines actually recommend, and the safety considerations worth knowing about. The rest of this section gets into specifics — muscle preservation, starting from zero, strength training, walking programs, and timing around your injections.
The Big Reframe: It's Not About Burning Calories
In 2024, the American College of Sports Medicine published its first exercise consensus statement for people on anti-obesity medications — the first update to their exercise-and-obesity guidelines in 15 years. And the central message was a fundamental shift in how we think about exercise during medical weight loss.[1]
Here’s how they put it: because medications like GLP-1s are so effective at producing weight loss on their own, the focus can shift away from burning calories and toward what exercise actually does best — improving how the body functions.[1]
That’s a big deal. For decades, the exercise conversation around weight loss has been dominated by calorie math. Burn more than you eat. Run it off. Earn your food. That framework was never great science, but it’s especially irrelevant when the medication is already handling the caloric deficit for you.
Exercise on a GLP-1 isn’t about accelerating weight loss. It’s about deciding what kind of health you end up with on the other side.
What Exercise Actually Does for GLP-1 Users
The medication takes weight off. Exercise decides what kind of weight — and fills in the gaps the medication can’t.
Preserves your muscle — Resistance training tells your body to keep muscle during weight loss. Without that signal, lean mass goes too.
Builds cardiovascular fitness — GLP-1s don't improve VO2max on their own. Exercise is the only way to build heart and lung fitness.
Protects your bones — Exercise completely negated bone density loss from GLP-1 treatment in a 2024 JAMA study.
Doubles the results — The S-LiTE trial showed medication + exercise was the only combination that improved body composition, insulin sensitivity, AND cardiovascular fitness.
It Preserves Your Muscle
When you lose weight — by any method — your body doesn’t only burn fat. It breaks down muscle too. On GLP-1 medications, clinical trials show that roughly 25-40% of weight lost can be lean mass, including muscle.[2] That’s not a failure of the medication. It’s a predictable consequence of rapid weight loss without enough stimulus to tell your body “keep the muscle.”
Resistance training is what sends that signal. The ACSM consensus was explicit: lean body mass improved only in the resistance exercise group, not in people doing cardio alone.[1] We’ll go deep on this in the muscle preservation page, but the takeaway here is straightforward — if you’re not doing some form of resistance training, your body has no reason to hold onto muscle it doesn’t think you’re using.
It Builds the Fitness the Medication Can’t
Here’s something that surprised researchers and might surprise you too: GLP-1 medications do not improve cardiorespiratory fitness on their own. A 2025 study from the University of Virginia found that despite significant weight loss, people on GLP-1s showed no improvement in VO2max — the gold standard measure of cardiovascular fitness.[3]
Why does that matter? Because cardiorespiratory fitness is, in the researchers’ own words, “far superior to overweight or obesity status for predicting the risk of death.”[3] In plain language: being fit matters more than being thin. Weight loss alone doesn’t get you there. Exercise does.
Despite driving significant weight loss, GLP-1 medications don’t improve cardiovascular fitness on their own. A 2025 UVA study found no improvement in VO2max — the standard measure of heart and lung fitness — without exercise. The researchers noted that cardiorespiratory fitness is a stronger predictor of mortality risk than weight itself. Source: University of Virginia / JCEM, 2025
It Protects Your Bones
Weight loss — especially rapid weight loss — can reduce bone density. That’s true for any method, including GLP-1 medications. But a 2024 study published in JAMA Network Open found that exercise completely negated the bone density loss associated with GLP-1 treatment. People on liraglutide alone lost bone density at the hip, spine, and forearm. People who exercised while taking liraglutide preserved bone density at all three sites.[4]
That’s not “exercise helped a little.” That’s exercise fully solving the problem.
The Combination Is Twice as Effective
The best evidence for exercise + GLP-1 medications comes from the S-LiTE trial, published in the New England Journal of Medicine. It compared four groups: GLP-1 medication alone, exercise alone, medication plus exercise, and placebo.[5]
| Group | Weight Loss | Body Composition | Insulin Sensitivity | VO2max |
|---|---|---|---|---|
| Medication Alone | -6.8 kg | Improved | Improved | No change |
| Exercise Alone | -4.1 kg | Improved | No change | Improved |
| Medication + Exercise | -9.5 kg | Improved | Improved | Improved |
The combination group was the only group that improved all three key outcomes: body composition (less fat, more preserved muscle), insulin sensitivity, and cardiorespiratory fitness.[5] Medication alone couldn’t do it. Exercise alone couldn’t do it. Only the combination covered all the bases.
From my experience, that trial basically confirmed what I’d already felt. The medication handled my appetite and the weight started coming off — but it was exercise that made me feel different. Stronger. More energy. Sleeping better. The scale was one thing. How my body actually performed was something else entirely. And the research backs that up.
What the Guidelines Actually Say
Multiple major organizations have published exercise recommendations for people on GLP-1 medications. Here’s what they agree on:
150+ Minutes Per Week
Moderate-intensity aerobic activity — the universal baseline from ACSM, Delphi, and ADA.[1][6][7] A brisk walk, cycling, or swimming all count.
2-3 Days Per Week of Resistance Training
Essential — not optional — for preserving muscle and protecting bones during GLP-1 weight loss.[1][6][7] This is the piece most people skip.
No single mode is superior — do what you’ll actually do. The ACSM was refreshingly direct: there’s no evidence that any one type of exercise produces better outcomes than another for people on these medications.[1] HIIT is not magic. Running is not required. What matters is that you do something consistently.
Break up sitting time. The ADA now recommends breaking up prolonged sitting every 30 minutes with at least 3 minutes of light activity — updated from their previous 90-minute recommendation.[7] Even short movement breaks improve blood sugar management.
When I first saw “150 minutes per week,” my immediate reaction was “I don’t have time for that.” Then I did the math. That’s about 22 minutes a day, or five 30-minute walks. When you break it down, it’s a lot less intimidating than it sounds. I started with walking and added resistance training later — and honestly, the resistance training is what made the biggest visible difference. But the walking is what got me moving in the first place. Start wherever you can.
Safety First: What to Watch For
Exercise on a GLP-1 is generally safe. But there are a few things worth paying attention to.
GLP-1 medications already increase dehydration risk through GI side effects, suppressed thirst signals, and reduced food intake. Sweating during exercise compounds all three. Pre-hydrate before exercise, sip during, and don't wait until you feel thirsty.[8]
Hypoglycemia is rare on GLP-1 medications alone (under 2% in trials).[9] But if you're also taking insulin or sulfonylureas, the risk goes up — and exercise lowers blood sugar further. Discuss this with your provider if you're on multiple diabetes medications.
GLP-1 medications cause a small increase in resting heart rate — about 2-4 bpm on average. Research shows this is clinically insignificant. The SELECT trial showed fewer cardiac events on semaglutide despite the slight bump.[10] Normal exercise heart rate targets still apply.
When you increase your dose, GI symptoms peak for a few days. Don't skip exercise entirely — dial back the intensity. A gentle walk is better than nothing, and light movement can actually help with nausea. Save the hard workouts for when you feel more settled.
The Bottom Line
Exercise on a GLP-1 medication isn’t punishment for eating. It isn’t about burning calories or earning your weight loss. It’s the other half of the equation — the half the medication can’t handle on its own.
GLP-1s handle appetite and weight. Exercise handles everything else: muscle preservation, cardiovascular fitness, bone density, insulin sensitivity, energy, mood, sleep. The research is clear that the combination produces outcomes neither approach can achieve alone.
The best exercise is the one you’ll actually do. Start where you are. The pages ahead cover how to preserve muscle during weight loss, how to start exercising from zero, strength training fundamentals, walking programs, and how to time exercise around your injections.
You don’t need to become a gym person. You just need to move — consistently, intentionally, and in ways that serve the body you’re building.
Sources:
- Donnelly JE, et al. “American College of Sports Medicine Consensus Statement on Exercise for Anti-Obesity Pharmacotherapy and Bariatric/Metabolic Surgery.” Medicine & Science in Sports & Exercise, 2024.
- Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine (STEP 1), 2021.
- University of Virginia Health. “GLP-1 Drugs Fail to Provide Key Weight-Loss Benefit, UVA Research Reveals.” Journal of Clinical Endocrinology & Metabolism, 2025.
- Jensen SBK, et al. “Effect of Maintenance of Clinically Significant Weight Loss Following Liraglutide 3.0 mg Treatment on Bone Health.” JAMA Network Open, 2024.
- Lundgren JR, et al. “Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.” New England Journal of Medicine, 2021.
- International Expert Panel. “Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: An expert consensus statement using a modified Delphi approach.” Obesity Pillars, 2025.
- American Diabetes Association. “5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes — 2026.” Diabetes Care, 2026.
- New Atlas. “Kidney warning issued for all GLP-1 drugs as FDA calls for label change.” 2025.
- National Center for Biotechnology Information (NCBI). “Tirzepatide.” StatPearls, 2024.
- Bostrom K, et al. “Heart rate effects of GLP-1 receptor agonists — the clinical perspective.” Cardiovascular Research, 2024.
Want to Start Tracking Your Progress?
Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.
View Templates